The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

Looking for weight loss options? GLP-1 agonist medications, originally designed to manage type 2 diabetes, are now ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Pharmacists must verify a person’s body mass index (BMI) via a video consultation, in person, or through accessing GP or ...

insurers often don't pay for these drugs for weight loss. List prices exceed $1,000 per month and spotty insurance coverage means many consumers struggle to afford the medications, researchers said.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

‘Wonder drugs’ like Ozempic, hailed by celebrities and some medics as a cure for an ever-mounting list of conditions ... 30 after taking a drug for weight loss — something it is not licensed ...

One study compared GLP-1RAs against another weight loss drug, bupropion-naltrexone ... As these drugs continue to gain popularity and achieve commercial success, their list of indications may also ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...